Ludwig Hantson
2017
In 2017, Ludwig Hantson earned a total compensation of $15.3M as Chief Executive Officer at Alexion Pharmaceuticals.
Compensation breakdown
| Non-Equity Incentive Plan | $2,275,000 |
|---|---|
| Option Awards | $2,282,881 |
| Salary | $900,000 |
| Stock Awards | $9,618,758 |
| Other | $233,428 |
| Total | $15,310,067 |
Hantson received $9.6M in stock awards, accounting for 63% of the total pay in 2017.
Hantson also received $2.3M in non-equity incentive plan, $2.3M in option awards, $900K in salary and $233.4K in other compensation.
Rankings
In 2017, Ludwig Hantson's compensation ranked 277th out of 14,666 executives tracked by ExecPay. In other words, Hantson earned more than 98.1% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 277 out of 14,666 | 98th |
Division Manufacturing | 85 out of 5,772 | 99th |
Major group Chemicals And Allied Products | 22 out of 2,075 | 99th |
Industry group Drugs | 17 out of 1,731 | 99th |
Industry Pharmaceutical Preparations | 15 out of 1,333 | 99th |
Source: SEC filing on March 26, 2019.
Hantson's colleagues
We found five more compensation records of executives who worked with Ludwig Hantson at Alexion Pharmaceuticals in 2017.
2017
Paul Clancy
Alexion Pharmaceuticals
Chief Financial Officer
2017
Julie O'Neill
Alexion Pharmaceuticals
Former Executive Vice President of Global Operations
2017
Brian Goff
Alexion Pharmaceuticals
Executive Vice President and Chief Commercial Officer
2017
John Orloff
Alexion Pharmaceuticals
Executive Vice President, Head of Research & Development
2017
Anne-Marie Law
Alexion Pharmaceuticals